Table 1 Clinical and biological characteristics of patients
From: Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression
Cases | TT | NT |
|---|---|---|
Total cases (n = 34) | 21 | 13 |
Age at diagnosis (years) | ||
< 49 | 0 | 0 |
50–59 | 2 | 2 |
60–69 | 11 | 8 |
> 70 | 8 | 3 |
Baseline PSA (ng/mL) | ||
< 4 | 0 | 0 |
4–10 | 8 | 9 |
10–20 | 8 | 4 |
> 20 | 5 | 0 |
Clinical stage | ||
T1c | 7 | - |
T2 | 8 | - |
T3 | 6 | - |
Gleason Score | ||
≤ 7 | 10 | - |
> 7 | 11 | - |